Madrigal Pharmaceuticals Inc.

06/25/2022 | Press release | Distributed by Public on 06/25/2022 07:29

Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™